Few Pediatric Cancer Drugs Reach Phase 3 or Approval

7 hours ago
1 min read

Most anticancer drugs that enter clinical testing in children and adolescents fail to reach late-phase trials or earn pediatric regulatory approval, according to the authors of new research.

Comments

Few Pediatric Cancer Drugs Reach Phase 3 or Approval

Childhood leukaemia and germs: research reveals the critical importance of timing

Local anaesthetic shows promise in blocking childhood cancer spread, study finds

Understanding best friendships and psychosocial health in pediatric brain tumor survivors

Living near a gas station raises childhood cancer risk, study shows

Gentler blood cancer treatment could boost survival and quality of life

Blocking Energy Metabolism May Help Treat Aggressive Pediatric Brain Tumor

MIT study finds children more vulnerable to cancer-causing chemical in water

Repurposed drugs could improve treatment for rare infant leukaemia

Blood test powered by AI shows early promise in monitoring rare childhood cancer

Recent Posts

Few Pediatric Cancer Drugs Reach Phase 3 or Approval

Comments

Few Pediatric Cancer Drugs Reach Phase 3 or Approval

Childhood leukaemia and germs: research reveals the critical importance of timing

Local anaesthetic shows promise in blocking childhood cancer spread, study finds

Understanding best friendships and psychosocial health in pediatric brain tumor survivors

Living near a gas station raises childhood cancer risk, study shows

Gentler blood cancer treatment could boost survival and quality of life

Blocking Energy Metabolism May Help Treat Aggressive Pediatric Brain Tumor

MIT study finds children more vulnerable to cancer-causing chemical in water

Repurposed drugs could improve treatment for rare infant leukaemia

Blood test powered by AI shows early promise in monitoring rare childhood cancer

Archive

Search By Tags